Thermo Fisher Q2 Earnings Beat Estimates, Guidance Lifted

Core Insights - Thermo Fisher Scientific (TMO) reported better-than-expected second-quarter earnings and raised its full-year projections [1][5] - The company experienced a 14% year-over-year increase in net income to $1.55 billion, surpassing analysts' expectations of$1.41 billion [1][2] - Revenue slightly decreased by 1% to $10.54 billion, but still exceeded the projected$10.52 billion [2][5] Financial Guidance - Analysts project full-year revenue around $42.95 billion and adjusted EPS of$21.70, both within Thermo Fisher's updated guidance ranges [4] - The company has adjusted its full-year revenue projection to a range of $42.4 billion to$43.3 billion, raising the lower end from the previous range of $42.3 billion to$43.3 billion [8] - Adjusted EPS projections have also been increased to a range of $21.29 to$22.07 per share, compared to the previous guidance of $21.14 to$22.02 per share [8] Market Reaction - Despite the earnings beat and raised guidance, Thermo Fisher shares fell by 1.7% to $543.00 in premarket trading [5][7] - The company had previously issued warnings about a potentially lower sales outlook at the beginning of the year, making the solid Q2 results significant [6]